Background Androgenic alopecia is common, chronic dermatologic disorder. A variety of lasers and light sources appear to be safe and effective in the treatment of AGA. Aims To evaluate the efficacy and safety of 1540‐nm fractional erbium glass laser in the treatment of AGA. Patients/Methods This was an interventional therapeutic study for the treatment of patients with AGA. The patients received 10 sessions with 1540‐nm fractional erbium glass laser at 2‐week intervals. The assessment of the response was done before and at the end of follow‐up period, both objectively (the change in the density of terminal hair and the diameter of the hair shaft) and subjectively (patient satisfaction). Any adverse effects were documented during the study. Results Forty‐seven out of 51 patients completed the study. After 5 months of laser treatment, the density of hair and hair thickness was significantly increased in both males and females (P value .001). Conclusion The 1540‐nm fractional erbium‐glass laser seems to be an effective and safe option for treatment of patients with AGA. The improvement was accomplished in a short period.

Background: This study was done to treat patients with androgenetic alopecia by using a new procedure, follicular unit extraction. Aim of study: To evaluate the efficacy and safety of Follicular Unit Extraction Hair Transplant in the treatment of androgenic alopecia patientsMethodology: The consultation establishes whether the patient is a candidate or not for hair transplantation. A complete history, including the age of onset, previous hair transplants, and scalp surgeries as well as scar formation, also medical, smoking, family and hair loss history were obtained. These patients were followed up to look for the time period of initiation of hair growth, the growth achieved at the end of 3–6 months and any adverse events. The results of patients with noticeable improvement in the photographs and patient satisfaction were recorded at 3&6 months after the procedure.Results: Thirty-five patients were treated with this new procedure. The hair growth started after three months and density of hair increase after six months. Three patients (8%) developed postural hypotension immediately postoperative and improve by changing position. Slight pain and burning sensation at donor site were recorded in all patients and relieved by taking simple analgesia.Conclusion: This is a new procedure for treating hair loss in males with androgenic alopecia, that does not leave scars and it is appealing satisfied for both patient and doctor.Recommendations: we recommend the application of procedure for larger group of patients to assess their effectiveness.

The intense pulsed light (IPL) therapy has three mechanisms of action in acne vulgaris: photochemical, photoimmunological, and photothermal. In this clinical trial, 47 patients with facial inflammatory acne lesions, ages ranging from 15 to 40 years, were enrolled. Patients were categorized into two groups: (a) 20 patients in Group A treated with IPL for 3 sessions, 3 weeks apart, (b) and 27 patients in Group B treated with benzoyl peroxide (BPO) 2.5% gel daily at night for 9 weeks. Follow up was done at 3 weeks after the end of treatment. The effect of treatment was evaluated objectively according to total lesion counting and digital photographic assessment and subjectively according to the patients' satisfaction. IPL is an effective and well-tolerated method for the treatment of inflammatory facial acne like BPO. Therefore, the IPL can be used as a standard therapy for inflammatory acne vulgaris.